Evidence map›Paper›PMID 19834104›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2010

Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Thomas M van Himbergen, Seiko Otokozawa, Nirupa R Matthan, Ernst J Schaefer, Aaron Buchsbaum, Masumi Ai, Lambertus J H van Tits, Jacqueline de Graaf, Anton F H Stalenhoef

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Thomas M van HimbergenLipid Metabolism Laboratory, Tufts University, 711 Washington Street, Boston, MA 02111-1524, USA. thomas.vanhimbergen@tufts.edu
Seiko Otokozawa
Nirupa R Matthan
Ernst J Schaefer
Aaron Buchsbaum
Masumi Ai
Lambertus J H van Tits
Jacqueline de Graaf
Anton F H Stalenhoef
Radboud University Nijmegen · NL

Funding

Weight Loss, Inflammation, and Vascular RemodelingP50HL083813 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELTY, FRANCINE K · 2006 to 2015
$13.0M
Pharmacogenetics of the Statin ResponseR01HL074753 · NHLBI · TUFTS UNIVERSITY BOSTON · PI SCHAEFER, ERNST JOHN · 2003 to 2006
$3.1M
MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCYR01HL060935 · NHLBI · TUFTS UNIVERSITY BOSTON · PI SCHAEFER, ERNST JOHN · 1999 to 2009
$2.2M
TRAINING PROGRAM IN HUMAN NUTRITION AND METABOLISMT32DK007651 · NIDDK · TUFTS UNIVERSITY BOSTON · PI MASON, JOEL B · 1990 to 2009
$1.9M
NHLBI NIH HHS HL 74753NHLBI NIH HHS O50HL083813NHLBI NIH HHS P50 HL083813NHLBI NIH HHS R01 HL060935NHLBI NIH HHS R01 HL074753NHLBI NIH HHS R01 HL-60935NIDDK NIH HHS DK07651NIDDK NIH HHS T32 DK007651
6 · The paper itself

Abstract

objectiveFamilial combined hyperlipidemia (FCH) is a common familial lipid disorder characterized by increases in plasma total cholesterol, triglyceride, and apolipoprotein B-100 levels. In light of prior metabolic and genetic research, our purpose was to ascertain whether FCH cases had significant abnormalities of plasma markers of cholesterol synthesis and absorption as compared to unaffected kindred members. METHODS AND

resultsPlasma levels of squalene, desmosterol, and lathosterol (cholesterol synthesis markers) and campesterol, sitosterol, and cholestanol (cholesterol absorption markers) were measured by gas-liquid chromatography in 103 FCH patients and 240 normolipidemic relatives (NLR). Squalene, desmosterol, and lathosterol levels were 6% (0.078), 31%, (P<0.001) and 51% (P<0.001) higher in FCH as compared to NLR, and these differences were especially pronounced in women. An interaction with obesity was also noted for a subset of these markers. We did not observe any apparent differences for the cholesterol absorption markers among FCH patients and NLR.

conclusionsOur data indicate that both men and women with FCH have alterations in the cholesterol synthesis pathway, resulting in 51% higher levels of lathosterol (and additionally desmosterol in women). Plasma levels of the cholesterol precursor sterol squalene were only slightly increased (6%), suggesting enhanced conversion of squalene to lathosterol in this disorder.

Indexed as

AdultAgedBiomarkersCholestanolCholesterolDesmosterolFemaleHumansHyperlipidemia, Familial CombinedIntestinal AbsorptionMaleMiddle AgedPhytosterolsSex CharacteristicsSitosterolsSqualeneBiomarkerscampesterolCholestanolCholesterolDesmosterolgamma-sitosterollathosterolPhytosterolsSitosterolsSqualene

Identifiers

PMID19834104
PMCPMC2813691
OpenAlexW2107481891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.